Fibromyalgia Syndrome on Anthropometric and Ultrasonographic Measurements in Obstructive Sleep Apnea Syndrome
- Conditions
- Fibromyalgia SyndromeObstructive Sleep Apnea Syndrome
- Registration Number
- NCT06536894
- Lead Sponsor
- Kirsehir Ahi Evran Universitesi
- Brief Summary
Obstructive type sleep apnea syndrome is a clinical condition characterized by apnea, hypopnea and oxygen desaturation due to narrowing of the upper airway during sleep. Obesity is considered a major predisposing factor for OSAS. In addition, various recent studies have reported that various anthropometric measurements such as neck circumference, waist circumference, hip circumference, waist-hip ratio, neck-waist circumference ratio change (increase) in OSAS patients.
- Detailed Description
Fibromyalgia is a common health problem that is characterized by pain in various parts of the body and is very difficult to diagnose and treat. It affects 2-4% of the population and is more common in women. The presence of OSAS in fibromyalgia patients is more common than in the normal population. There are also common additional symptoms such as excessive daytime sleepiness and delayed sleep latency.
Although it has been reported that the presence of OSAS is more common in fibromyalgia patients, there is no study on the presence of anthropometric measurements, especially neck circumference, that are accepted in OSAS.
The aim of this study is to compare the anthropometric and ultrasonographic measurements of female OSAS patients with and without fibromyalgia.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 60
- Between 18-65 years old
- Being diagnosed with fibromyalgia and having applied to the sleep disorders outpatient clinic or being followed up with the diagnosis of OSAS in the sleep disorders outpatient clinic.
- Agree to participate in the study
- Patients under 18 years of age
- Male patients
- Not agreeing to participate in the study
- Neurological diseases that may cause OSAS such as stroke, Parkinson's disease, multiple sclerosis
- Rheumatological, oncological and hematological diseases
- Central type obstructive sleep apnea syndrome
- Thyroid pathology that affects neck circumference measurement
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Polisomnografi -SLEEP ACTIVITY Day 0 ( Baseline) Sleep efficiency will be measured during polysomnography
Polisomnografi-REM Day 0 ( Baseline) REM times will be evaluated in polysomnography
submental ultrasonography Day 0 ( Baseline) All patients will undergo submental ultrasonography to measure tongue base thickness and lateral pharyngeal wall thickness.
Polisomnografi -NREM STAGES Day 0 ( Baseline) During polysomnography, NREM stages will be measured at 1 min, 2 min, and 3 min.
Polisomnografi -NUMBER OF HYPOPNEA Day 0 ( Baseline) Numbers of hypopnea will be recorded in polysomnographic measurements
Polisomnografi-NonREM Day 0 ( Baseline) NonREM times will be evaluated in polysomnography
Polisomnografi- SLEEP LATENCE Day 0 ( Baseline) Sleep latency time will be measured in polysomnography
Polisomnografi -REM time Day 0 ( Baseline) REM time will be measured in minutes during polysomnography
Polisomnografi - NUMBERS OF APNE Day 0 ( Baseline) Numbers of apnea will be recorded in polysomnographic measurements.
Polisomnografi -Apnea hypopnea index (AHI) in polysomnography; Apnea hypopnea index (AHI) will be evaluated on a supine, non-supine basis. Day 0 ( Baseline) Apnea hypopnea index (AHI) will be evaluated in polysomnography.According to the AHI level; It will be classified as SIMPLE SNORING (AHİ\<5), LIGHT OSAS (AHİ 5-15), MEDIUM OSAS (AHİ 15-30), HEAVY OSAS (AHİ 30+ )
Anthropometric Measurements Day 0 ( Baseline) Anthropometric measurements will be taken for all patients. These measurements include neck circumference, waist circumference, hip circumference, and with these data, waist-hip ratio and neck-waist circumference ratio will be calculated. Measurements will be made with a tape measure and with patient consent.
Polisomnografi -Apnea hypopnea index (AHI) REM, NONREM in polysomnography; Apnea hypopnea index (AHI) will be evaluated on a supine, non-supine basis. Day 0 ( Baseline) Apnea hypopnea index (AHI) will be evaluated as REM, NONREM, Supine, non-supine in polysomnography.According to the AHI level; It will be classified as SIMPLE SNORING (AHİ\<5), LIGHT OSAS (AHİ 5-15), MEDIUM OSAS (AHİ 15-30), HEAVY OSAS (AHİ 30+ )
Polisomnografi -OXYGEN DESATURATION INDEX Day 0 ( Baseline) Minimum oxygen saturation and average oxygen saturation will be measured in polysomnography.
- Secondary Outcome Measures
Name Time Method Pittsburgh Sleep Quality Index Day 0 ( Baseline) The Pittsburgh Sleep Quality Index will be used to evaluate sleep quality. The survey consists of 21 questions and a high score indicates poor sleep quality.
Fibromyalgia Impact Scale Day 0 ( Baseline) The fibromyalgia levels of the participants will be evaluated with the Fibromyalgia Impact Scale. High scores indicate increased disease activity. Consists of 10 questions Maximum score is 80. Turkish validity and reliability was done